Alzheimer Disease or Associated Disorder
Conditions
Keywords
Alzheimer's disease, Music intervention, Behavior disorder
Brief summary
As the Alzheimer's disease progresses, caregivers and family members often focus on behavioral difficulties. In response to crises, immediate actions tend to favor restraints, either through medication or physical means. This work aims to improve the management of behavioral disturbances in patients with Alzheimer's disease through musical interventions (group or individual), particularly in advanced stages of the disease, where medical and family resources are insufficient. The investigators approach prioritizes NTM over medication as a mean to improve patient well-being. To this end, they have designed a study. The study focuses on creating a conducive environment for sleep by incorporating ritualized, familiar music sessions supervised by nursing staff after meals. To conduct this study, the actigraphy will be used to analyze participants' behavior both day and night, complemented by questionnaires and clinical observations.
Interventions
BEHAVIORALMusic intervention - passive listening
Diffusion of familiar music in the bedrooms and living room before bedtime; passive and individual listening.
BEHAVIORALAudio books intervention - active listening
Dynamic audio book listening, akin to active listening while respecting the rhythm of the evening . This type of listening involves concentrating specifically .
Sponsors
Centre Hospitalier Universitaire de Saint Etienne
Study design
Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Non-opposition of the patient's legal guardian. * Patients aged 60 and over, meeting the diagnostic criteria for Alzheimer's disease and related disorders. * Patients living in a Protected Living Unit (PLU) * If consuming psychotropic medications, they must have been stabilized for 3 months. * If consuming level 2 or 3 analgesics, they must have been stabilized for 1 month.
Exclusion criteria
* Refusal to participate. * Participation in a study on a drug /medical device / care technique that could affect sleep or behavior during the study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Sleep duration | Days 1 to 51 | Sleep duration will be measured by actigraphy (bracelet worn by the participants). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Sleep onset and nocturnal awakenings reduction | Days 1 to 51 | Sleep onset latency and number of nocturnal awakenings measured by actigraphy. |
| Daytime agitation reduction | Days 1 to 51 | Cohen-Mansfield Agitation Inventory score, which assesses 29 items including: non-aggressive physical agitation (1-13), non-aggressive verbal agitation (14-17), physical agitation and aggression (18-26), and verbal agitation and aggression (27-29). A high score reflects intense agitation. |
| Mood improvement | Days 1 to 51 | Caregiver questionnaire: category scale : for agitation and mood. |
| Falls number reduction | Days 1 to 51 | Fall questionnaire include in the caregiver questionnaire. |
Countries
France
Contacts
CONTACTIsabelle ROUCH, Md
CONTACTCéline BORG, PhD
PRINCIPAL_INVESTIGATORIsabelle ROUCH, Md
CHU de Saint-Etienne
Outcome results
None listed